Sickle Cell Anemia Research Fdn Inc
EIN: 720792655 · Alexandria, LA · NTEE: P20
| Metric | Value |
|---|---|
| Total Revenue | $227K |
| Total Expenses | $179K |
| Net Assets | $81K |
Is Sickle Cell Anemia Research Fdn Inc Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Sickle Cell Anemia Research Fdn Inc
Sickle Cell Anemia Research Fdn Inc (EIN: 720792655) is a nonprofit organization based in Alexandria, LA, classified under NTEE code P20. The organization reported total revenue of $227K and total assets of $144K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Sickle Cell Anemia Research Fdn Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Sickle Cell Anemia Research Fdn Inc is a small nonprofit that has been operating for 12 years, with 14 years of IRS 990 filings on record (2008–2023). Revenue has grown at a compound annual rate of 3.8%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $237K |
| Total Expenses | $179K |
| Surplus / Deficit | +$58K |
| Total Assets | $113K |
| Total Liabilities | $33K |
| Net Assets | $81K |
| Operating Margin | 24.6% |
| Debt-to-Asset Ratio | 28.6% |
| Months of Reserves | 7.6 months |
Financial Health Grade: A
In 2023, Sickle Cell Anemia Research Fdn Inc reported a surplus of $58K with revenue exceeding expenses, holds 7.6 months of operating reserves (strong position), has a debt-to-asset ratio of 28.6% (moderate leverage).
Financial Trends
Over 14 years of filings (2008–2023), Sickle Cell Anemia Research Fdn Inc's revenue has grown at a compound annual growth rate (CAGR) of 3.8%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +112.5% | -10.4% | +398.7% |
| 2022 | +293.0% | +223.8% | -75.6% |
| 2021 | +52.5% | -23.7% | -3.3% |
| 2020 | -80.7% | -20.2% | -21.8% |
| 2019 | +68.3% | +109.5% | -3.8% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2014 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Sickle Cell Anemia Research Fdn Inc has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Sickle Cell Anemia Research Fdn Inc with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $58K, with revenue exceeding expenses.
- Debt-to-asset ratio: 28.6%.
Frequently Asked Questions about Sickle Cell Anemia Research Fdn Inc
Is Sickle Cell Anemia Research Fdn Inc a legitimate charity?
Sickle Cell Anemia Research Fdn Inc (EIN: 720792655) is a registered tax-exempt nonprofit based in Louisiana. It has 14 years of IRS 990 filings on record. Total revenue: $227K. No red flags identified. Financial health grade: A.
How does Sickle Cell Anemia Research Fdn Inc spend its money?
Sickle Cell Anemia Research Fdn Inc reported $227K in total revenue in IRS 990 filings. 14 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Sickle Cell Anemia Research Fdn Inc tax-deductible?
Sickle Cell Anemia Research Fdn Inc is registered as a tax-exempt nonprofit (EIN: 720792655). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Sickle Cell Anemia Research Fdn Inc located?
Sickle Cell Anemia Research Fdn Inc is headquartered in Alexandria, Louisiana and files with the IRS under EIN 720792655. It is classified under NTEE code P20.
How many years of IRS 990 filings does Sickle Cell Anemia Research Fdn Inc have?
Sickle Cell Anemia Research Fdn Inc has 14 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $227K in total revenue.
Filing History
IRS 990 filing history for Sickle Cell Anemia Research Fdn Inc showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2008–2023), Sickle Cell Anemia Research Fdn Inc's revenue has grown by 75.5%, moving from $135K to $237K. Total assets increased by 45.6% over the same period, from $78K to $113K. Total functional expenses rose by 309%, from $44K to $179K. In its most recent filing year (2023), Sickle Cell Anemia Research Fdn Inc reported a surplus of $58K, with revenue exceeding expenses. The organization holds $33K in liabilities against $113K in assets (debt-to-asset ratio: 28.6%), resulting in net assets of $81K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $237K | $179K | $113K | $33K | — | View 990 |
| 2022 | $112K | $200K | $23K | $0 | — | View 990 |
| 2021 | $28K | $62K | $93K | $65K | — | View 990 |
| 2020 | $19K | $81K | $97K | $35K | — | View 990 |
| 2019 | $96K | $101K | $124K | $0 | — | View 990 |
| 2018 | $57K | $48K | $128K | $0 | — | View 990 |
| 2017 | $40K | $42K | $119K | $0 | — | View 990 |
| 2016 | $89K | $71K | $121K | $0 | — | — |
| 2015 | $64K | $72K | $121K | $10K | — | View 990 |
| 2014 | $91K | $79K | $119K | $113 | — | View 990 |
| 2013 | $82K | $83K | $107K | $0 | — | — |
| 2012 | $101K | $97K | $108K | $2K | — | — |
| 2011 | $142K | $138K | $105K | $3K | — | — |
| 2008 | $135K | $44K | $78K | $2K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $237K, expenses of $179K, and assets of $113K (revenue +112.5% year-over-year).
- 2022: Revenue of $112K, expenses of $200K, and assets of $23K (revenue +293.0% year-over-year).
- 2021: Revenue of $28K, expenses of $62K, and assets of $93K (revenue +52.5% year-over-year).
- 2020: Revenue of $19K, expenses of $81K, and assets of $97K (revenue -80.7% year-over-year).
- 2019: Revenue of $96K, expenses of $101K, and assets of $124K (revenue +68.3% year-over-year).
- 2018: Revenue of $57K, expenses of $48K, and assets of $128K (revenue +44.8% year-over-year).
- 2017: Revenue of $40K, expenses of $42K, and assets of $119K (revenue -55.7% year-over-year).
- 2016: Revenue of $89K, expenses of $71K, and assets of $121K (revenue +40.8% year-over-year).
- 2015: Revenue of $64K, expenses of $72K, and assets of $121K (revenue -30.4% year-over-year).
- 2014: Revenue of $91K, expenses of $79K, and assets of $119K (revenue +11.4% year-over-year).
- 2013: Revenue of $82K, expenses of $83K, and assets of $107K (revenue -18.6% year-over-year).
- 2012: Revenue of $101K, expenses of $97K, and assets of $108K (revenue -29.2% year-over-year).
- 2011: Revenue of $142K, expenses of $138K, and assets of $105K (revenue +5.2% year-over-year).
- 2008: Revenue of $135K, expenses of $44K, and assets of $78K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Sickle Cell Anemia Research Fdn Inc:
Data Sources and Methodology
This transparency report for Sickle Cell Anemia Research Fdn Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.